Abstract Plasmablastic lymphoma (PBL) is a rare aggressive neoplasm characterized by diffuse proliferation of large neoplastic cells with plasma cell immunophenotype. Cell of origin of PBL is believed to be a postgerminal center B-lymphocyte or plasmablast. The malignant cells in PBL usually do not express CD20 (B cell marker) but do express markers of plasmacytic differentiation, such as CD38, CD138, or MUM1/IRF4, akin to plasma cell myeloma (PCM). PBL though originally described in the oral cavity, has now been found to occur in extraoral locations as well. Small intestine as a site of PBL has been described very rarely. PBL remains a diagnostic challenge given its overlapping morphologic and immunophenotypic features with other high grade lymphomas and PCM. We report a rare case of PBL of small intestine in a 48 years old HIV infected male patient. To the best of our knowledge this represents sixth case in the literature described in this location. An unusual rare pattern of CD138 positivity by IHC is also reported along with extensive review of literature of PBL in extraoral locations. /L. CECT scan of abdomen revealed circumferential diffuse wall thickening of jejunal loop and enlarged mesenteric lymph nodes (Fig. 1) . After preoperative evaluation he underwent explorative laparotomy, resection of small bowel with end to end anastomosis and omentectomy.
/L. CECT scan of abdomen revealed circumferential diffuse wall thickening of jejunal loop and enlarged mesenteric lymph nodes (Fig. 1) . After preoperative evaluation he underwent explorative laparotomy, resection of small bowel with end to end anastomosis and omentectomy.
Screening tests for HIV I & II done by enhanced chemiluminescence method were reactive with test values being 85.1 (C1.0 reactive, gray zone 0.9-0.99,\0.9 non reactive). Absolute CD3, CD4 and CD8 counts and percentages were assessed by flow cytometry (FCM) technique as showed in Table 1 . Serum LDH and Uric acid levels were 702U/L (normal range 208-320U/L) and 4.7 mg/dl (normal range 3.5-7.2 mg/dL). Human immunodeficiency virus (HIV)-viral load as estimated by RT-PCR was 1,536,000 copies/ml (lowest limit of detection 40 copies/mL). Patient underwent explorative laparotomy, resection of small bowel, end to end anastomosis and omentectomy.
We received a segment of small intestine measuring 55 cm in length. On cutting open, an ulceroproliferative lesion measuring 7.5 9 3 9 1.5 cm was identified. The lesion was involving the intestine circumferentially. Corresponding serosal surface was irregular. The fat along mesenteric border appears involved. Omentum measured 35 9 5 9 2 cm and showed firm grey white areas.
Microscopic examination showed a tumor composed of large to intermediate sized lymphoid cells in sheets infiltrating the full thickness of bowel wall extending into adjacent fat with serosal involvement. The cells were large with round nuclei with small to prominent nucleoli and scanty cytoplasm ( Fig. 2A) . Some cells showed plasmacytoid morphology.
Frequent mitotic figures including atypical ones, focal area of necrosis and tingible body macrophages giving starry sky appearance were also noted. Four out of twenty-six lymph nodes examined showed involvement (4/26). Mesentric fat and omentum also showed lymphoma deposits. On immunohistochemistry, tumor cells were positive for leukocyte common antigen (LCA), MUM1, and CD138 ( Fig. 2B-D) . With CD138, tumor cells demonstrated cytoplasmic and perinuclear dot positivity. Ki-67 index was[90 % (Fig. 2E) . Epstein-Barr virus (EBV) infection was detected positive by in situ hybridization for EBV-encoded RNA (EBER ISH) (Fig. 2F) . Neoplastic cells were found to be negative for CD10, CD20, CD79a, Bcl2, Bcl6, PAX5, kappa & lambda light chains, CD3 and ALK1 (Fig. 3A-F) . C-myc repeated twice elsewhere was negative. Serology for HHV-8 was not done. Bone marrow aspiration and biopsy were performed and revealed normal marrow with mild eosinophilia.
Discussion
Plasmablastic lymphoma (PBL) was first described as a specific clinicopathologic entity by Delecluse et al. [1] as an aggressive B cell lymphoma occurring in the oral cavity arising in the context of HIV infection. However, in recent years, several cases of PBL have been reported at extraoral sites, including the skin, [2] subcutaneous tissue, [3] stomach, [4] anal mucosa or perianal area [5] , lung [6] lymph node [7] , and other regions. Small intestine has rarely been reported as a site for PBL with only five cases [8] [9] [10] [11] [12] reported in the literature before, present case being the sixth case. Table 2 summarizes all the cases reported at this location so far including the present case.
Genetic and molecular mechanisms that may be involved in the pathogenesis of PBL are not very well understood. Infection of the neoplastic cells by EBV which is present in most of the cases, seems to have very important role in the tumorigenesis of HIV-associated PBL. HIV infection creates a conducive environment for chronic EBV infection, with a subsequent latency period which predisposes the B-cells transformed by EBV to become malignant [7] .
The morphological differential diagnosis of PBL include Plasmablastic variant of multiple myeloma, Plasmablastic variant of Burkitt's lymphoma (BL), blastoid variant of mantle cell lymphoma (MCL), anaplastic large cell lymphoma kinase (ALK) positive diffuse large B-cell lymphoma (DLBCL), extracavitary primary effusion lymphoma (PEL), large B-cell lymphoma associated with human herpesvirus 8 (HHV-8) infection, Extramedullary myeloid tumor, poorly differentiated carcinoma and malignant melanoma.
Immunophenotypically, the neoplastic cells express a plasma cell phenotype including positivity for CD138, CD38, Vs38c and IRF4/MUM1 and are negative or only weakly positive for CD45, CD20 and PAX5. CD79a is positive in approximately 50-85 % of the cases. EMA and CD30 are frequently expressed. Ki67 index is usually very high ([90 %). EBV EBER in situ hybridization is positive in 60-75 % of the cases [13] .
In our case, plasma cell phenotype of neoplastic cells was evident by positivity for CD138 and MUM1. Immunostain for CD138 demonstrated cytoplasmic and perinuclear dot positivity in neoplastic cells unlike usual membranous pattern of staining in cases of PBL. Granular and golgi region positivity with CD138 similar to that seen in our case has been described previously in plasma cells in cases of multiple myeloma [14] . In addition, negativity for CD20, CD79a and PAX5, CD10, Bcl2, Bcl6, ALK1 helped in ruling out B cell lymphomas like BL and blastoid variant of MCL and ALK ? DLBCL. Our diagnosis was further supported by positivity for (EBV) infection detected by EBER ISH.
Rare HHV8-positive lymphomas indistinguishable from PEL present as solid tumour masses, and have been termed extracavitary PEL. These tumours with morphologic and phenotypic characteristics similar to PEL and occur in extranodal sites including the gastrointestinal tract, skin, lung. Morphologically, neoplastic cells show varied appearances Tumours with features of PBL may occur in patients with prior plasma cell neoplasm, including plasma cell myeloma (PCM). Such cases should be considered plasmablastic transformation of myeloma and must be distinguished from primary PBL. In many cases, the clinical features of the disease, such as osteolytic lesions, diffuse bone marrow involvement, and the presence of an M protein in the case of PCM or the frequent association with HIV infection, common manifestation in the oral cavity, and EBV positivity in PBL aid in arriving at the correct diagnosis. However, cases of PCM or PBL with atypical clinical features can pose significant diagnostic challenges [16] .
Bone marrow involvement in PBL may be seen, but the clinical disease distribution is that of a lymphoma rather than a PCM. In our case BM examination revealed a normal marrow with mild eosinophilia.
Poorly differentiated carcinoma and malignant melanoma might be considered in the differential diagnosis of PBL at this location. Poorly differentiated carcinoma may be differentiated from PBL according to its consistent immunological staining for cytokeratin. Malignant melanoma can be ruled out by using S-100 protein and HMB45.
PBL can also occur in HIV sero-negative patients. Cases of HIV-negative PBL have been mostly described after solid organ transplantation, in association with steroid therapy for autoimmune disease and some other types of immunosuppression. Castillo et al. [17] studied PBL arising in HIV-positive and HIV-negative individuals and concluded that these two groups have distinct clinical and pathological differences. Amongst the most notable clinical differences were that HIV positive PBL patients are younger, include a higher proportion of male cases, have more common oral involvement, and have a better response to chemotherapy than their HIV-negative counterparts.
MYC rearrangements are the most common recurrent structural chromosomal alteration identified in PBL, occurring in almost 50 % of the cases and the IG genes being the MYC partners in most tumors [18] . MYC rearrangement studies done in our case were found to be negative.
Conclusion
PBL is a distinct type of NHL, that most frequently affects the oral tissue of HIV-positive patients and that usually behaves very aggressively. Meticulous integration of clinical, morphological, phenotypic and molecular features is important for rendering the correct diagnosis which is quite difficult in the absence of an exhaustive workup. The diagnosis of such neoplasm might be even more challenging in the setting of extra-oral localizations and in immunocompetent patients. The presence of a high proliferation index, extra nodal location, history of immune deficiency and the presence of EBV by in situ hybridization helps in reaching to a diagnosis in most cases. Authors suggest that larger studies be carried out on such cases in order to establish criteria's to differentiate PBL from plasmablastic myeloma and high grade lymphoma.
